- Organization Overview
- Dean’s Office
- Dean’s Office Overview
- PharmD Education Unit
- Office of Administration
- Office of Communications
- Office of Faculty Academic Affairs
- Pharmacy Practice Partnerships
- Department of Bioengineering and Therapeutic Sciences
- Department of Clinical Pharmacy
- Department of Pharmaceutical Chemistry
- Quantitative Biosciences Institute
- Org Chart
- Patient Care
Meet Rosa Rodriguez-Monguio and Akinyemi Oni-Orisan
By UCSF School of Pharmacy Editorial Staff / Mon Feb 12, 2018
Rosa Rodriguez-Monguio, PhD
Rosa Rodriguez-Monguio, PhD, Professor of Clinical Pharmacy in the Department of Clinical Pharmacy, UCSF School of Pharmacy, has been appointed director of the Medication Outcomes Center, effective February 1, 2018.
Rodriguez-Monguio succeeds Bret Brodowy, PharmD, who served as director since August 2013 and retired in January 2018. Rodriguez-Monguio will work closely with Lisa Kroon, PharmD, chair of the Department of Clinical Pharmacy and executive director of the Medication Outcomes Center, and with the leadership of the UCSF Medical Center Department of Pharmaceutical Services, to advance the Center’s important work.
Rodriguez-Monguio is a health economist with over 15 years of experience in pharmaceutical economics and policy and health outcomes research. Prior to joining the faculty at UCSF, she was an associate professor (2007-2017) and head of the Health Policy and Management Program at the University of Massachusetts, Amherst. She was an associate researcher at the Center for Health Outcomes, Policy, and Evaluation Studies at the College of Public Health, Ohio State University, from 2004 to 2006.
Rodriguez-Monguio also worked as a health economist for the World Bank and the Pan American Health Organization (2001-2003) in Washington DC. She joined the UCSF Department of Clinical Pharmacy in October 2017.
Her current research interests include post-marketing drug safety, addressing the health and economic impacts of adverse drug events, drug shortages and interchangeability of therapeutic alternatives, and appropriateness of prescription and utilization patterns of pharmaceuticals, particularly opioid analgesics, antipsychotics, and systemic antibiotics. The overarching goal of her research is to enhance prescription drug safety and improve health outcomes while containing the cost of care.
About the Medication Outcomes Center: Established in 2007, the UCSF Medication Outcomes Center conducts state-of-the-art, medication-related economic evaluations and health outcomes research to enhance medication safety and patient-level outcomes.
Akinyemi Oni-Orisan, PharmD, PhD
Akinyemi Oni-Orisan, PharmD, PhD, joined the department as an assistant adjunct professor, effective October 1, 2017. He recently completed a postdoctoral fellowship in the Clinical Pharmacology Training Program at UCSF. Oni-Orisan will be investigating therapies for cardiovascular disease using precision medicine approaches.
When he is not conducting research, he enjoys playing soccer and traveling out of state to visit his nieces.
About the School: The UCSF School of Pharmacy aims to solve the most pressing health care problems and strives to ensure that each patient receives the safest, most effective treatments. Our discoveries seed the development of novel therapies, and our researchers consistently lead the nation in NIH funding. The School’s doctor of pharmacy (PharmD) degree program, with its unique emphasis on scientific thinking, prepares students to be critical thinkers and leaders in their field.